MBX Biosciences, Inc. Common Stock
(MBX - NASDAQ)
31,97 USD
📋 Profilo Aziendale

MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

|